CRWS
Crown Crafts, Inc.
CRWS has the edge over NKE overall, supported by stronger fundamentals and stronger valuation.
NKE
NIKE, Inc.
NKE has lower modeled downside risk, despite its lower overall score.
CRWS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
CRWS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
CRWS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 5.2x | $2.43 | — |
| Cheap | 7.2x | $3.39 | +39% |
| Fair | 9.9x | $4.65 | +91% |
| Expensive | 12x | $5.59 | +130% |
Historical ranges are pointers, not guarantees.
CRWS has the edge over NKE in the historical PE scenario, which offers more potential upside but is not a forecast.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 30x, in its fair range.
CRWS Forward outlook
There aren't enough analyst estimates for CRWS to show an outlook.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
CRWS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.47 | +$1.41 |
| Q2 2026 | $0.46 | +$1.43 |
| Q1 2026 | $0.17 | +$1.07 |
| Q4 2025 | -$0.89 | -487% |
| Q3 2025 | -$0.94 | -403% |
| Q2 2025 | -$0.97 | -337% |
| Q1 2025 | -$0.90 | -288% |
| Q4 2024 | $0.23 | -52% |
CRWS has the edge over NKE on earnings, with more consistent year-over-year improvement.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
CRWS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $19M | -20% |
| Q2 2026 | $16.8M | +8.3% |
| Q1 2026 | $22.4M | -3.7% |
| Q4 2025 | $20.7M | -11% |
| Q3 2025 | $23.7M | -3.1% |
| Q2 2025 | $15.5M | -4.5% |
| Q1 2025 | $23.2M | +2.9% |
| Q4 2024 | $23.4M | -1.9% |
CRWS's revenue has slid since its 2022 peak: $19M last quarter, down 20% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.4 points |
| Q2 2026 | 17% | +24 points |
| Q1 2026 | 2.4% | +63 points |
| Q4 2025 | -0.5% | -7.8 points |
| Q3 2025 | 7.9% | +1.7 points |
| Q2 2025 | -7.8% | -5.9 points |
| Q1 2025 | -61% | -67 points |
| Q4 2024 | 7.3% | -2.5 points |
CRWS's operating margin was 8.2% last quarter, about level with the same quarter a year ago.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE has the edge over CRWS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE's operating margin was 8.2% last quarter, about level with the same quarter a year ago.
CRWS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $5.4M | +$6.4M |
| Q2 2026 | $5.4M | +3.7% |
| Q1 2026 | $926K | -65% |
| Q4 2025 | $2.3M | +$2.6M |
| Q3 2025 | -$1M | +$155K |
| Q2 2025 | $5.2M | -33% |
| Q1 2025 | $2.6M | -8.5% |
| Q4 2024 | -$220K | +$451K |
CRWS has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
CRWS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +55K shares |
| 1 year | +1.7% | +181K shares |
| 3 years | +6% | +614K shares |
| 5 years | +7.1% | +721K shares |
| Available history | +6.3% | +638K shares |
CRWS has 11M diluted shares, up 1.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | $18,000 |
| Q4 2022 | — |
| Q3 2022 | $27,000 |
| Q2 2022 | $162,000 |
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has the edge over CRWS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
CRWS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.8x | Very low |
| Q2 2026 | 1.4x | Healthy |
| Q1 2026 | 5.3x | High |
| Q4 2024 | 3.5x | Elevated |
| Q3 2024 | 3.0x | Elevated |
| Q2 2024 | 0.1x | Very low |
| Q1 2024 | 0.9x | Very low |
| Q4 2023 | 1.2x | Healthy |
CRWS's net debt is less than a year of its operating earnings (EBITDA), down from 3.0 years a year ago.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE has the edge over CRWS on leverage, with a lower net debt burden relative to earnings.
CRWS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.8 | Neutral |
| Stochastic | 18.4 | Oversold |
CRWS's weekly RSI is 34 (neutral) and its Stochastic is 18 (oversold).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
CRWS PE vs Consumer Cyclical Sector
| Metric | CRWS | Sector median | Relative |
|---|---|---|---|
| PE | 5.2x | 18x | 71% below |
| PE % | 0 | 47 | 47 pts below |
CRWS has the edge over NKE on valuation relative to its sector.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
CRWS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.44 | 0.4% below |
| 20 week MA | $2.70 | 10% below |
| 50 week MA | $2.76 | 12% below |
| 100 week MA | $3.05 | 20% below |
| 200 week MA | $4.06 | 40% below |
CRWS is in a downtrend: it's below all five of its weekly moving averages, and 40% below its 200-week average.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has the edge over CRWS on trend strength, trading above more of its moving averages.
CRWS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.10 | $7.15 | +17% |
| 2021 | $7.15 | $7.04 | -1.5% |
| 2022 | $7.04 | $5.30 | -25% |
| 2023 | $5.30 | $4.96 | -6.4% |
| 2024 | $4.96 | $4.51 | -9.1% |
| 2025 | $4.51 | $2.67 | -41% |
| 2026 YTD | $2.67 | $2.43 | -9% |
CRWS has the edge over NKE on returns for 2026, with the stronger performance.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.